Muscle atrophy can be treated with appetite-stimulating hormoneResearchers have claimed to find a new form of treatment option to provide relief to patients suffering from muscle atrophy, as per results of an animal study that were presented at the Endocrine Society’s 91st Annual Meeting in Washington, D.C.

Muscular atrophy is a debilitating process resulting in an extensive loss of muscle mass and function to reduce quality of patients’ lives.

Some of the currently used treatment methodologies consist include anabolic steroids (testosterone) and insulin-like growth factor 1 (IFG-1) that may not appear to be safe, according to study co-author Andrea Graziani, PhD, molecular biologist with the Department of Clinical and Experimental Medicine and the Biotechnology Center for Applied Medical Research, University of Piemonte Orientale, Novara, Italy.

Researchers remarked that des-acyl ghrelin provides a direct anti-atrophic activity on the skeletal muscle of mice for the ailment caused by fasting or nerve injury.